SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309107130> ?p ?o ?g. }

Showing items 1 to 100 of ±102 with 100 items per page.

W4309107130 endingPage "111633" @default.
W4309107130 startingPage "111633" @default.
W4309107130 abstract "(Cell Reports 39, 110733; April 26, 2022) In the original published version of this paper, a declaration of interests was accidently omitted: “B.N.F. is a member of the scientific advisory board and has stock in Cirius Therapeutics, which is developing MPC inhibitors for clinical use.” This has been corrected online. The authors apologize for this error. Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acidsMartino et al.Cell ReportsApril 26, 2022In BriefMartino et al. find that alanine transaminase 2 (ALT2), which is encoded by Gpt2, is increased in liver of mice and people with obesity by activating transcription factor 4. Suppression of Gpt2 expression in obese, but not lean mice, lowers blood glucose by suppressing alanine-mediated gluconeogenesis. Full-Text PDF Open Access" @default.
W4309107130 created "2022-11-22" @default.
W4309107130 creator A5004748981 @default.
W4309107130 creator A5008108181 @default.
W4309107130 creator A5010497922 @default.
W4309107130 creator A5021042114 @default.
W4309107130 creator A5027513211 @default.
W4309107130 creator A5028794692 @default.
W4309107130 creator A5029688659 @default.
W4309107130 creator A5037741335 @default.
W4309107130 creator A5042024378 @default.
W4309107130 creator A5044402423 @default.
W4309107130 creator A5048321924 @default.
W4309107130 creator A5049712951 @default.
W4309107130 creator A5057320481 @default.
W4309107130 creator A5075010024 @default.
W4309107130 creator A5077263580 @default.
W4309107130 creator A5086648272 @default.
W4309107130 creator A5090313762 @default.
W4309107130 date "2022-11-01" @default.
W4309107130 modified "2023-09-26" @default.
W4309107130 title "Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids" @default.
W4309107130 doi "https://doi.org/10.1016/j.celrep.2022.111633" @default.
W4309107130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36384117" @default.
W4309107130 hasPublicationYear "2022" @default.
W4309107130 type Work @default.
W4309107130 citedByCount "0" @default.
W4309107130 crossrefType "journal-article" @default.
W4309107130 hasAuthorship W4309107130A5004748981 @default.
W4309107130 hasAuthorship W4309107130A5008108181 @default.
W4309107130 hasAuthorship W4309107130A5010497922 @default.
W4309107130 hasAuthorship W4309107130A5021042114 @default.
W4309107130 hasAuthorship W4309107130A5027513211 @default.
W4309107130 hasAuthorship W4309107130A5028794692 @default.
W4309107130 hasAuthorship W4309107130A5029688659 @default.
W4309107130 hasAuthorship W4309107130A5037741335 @default.
W4309107130 hasAuthorship W4309107130A5042024378 @default.
W4309107130 hasAuthorship W4309107130A5044402423 @default.
W4309107130 hasAuthorship W4309107130A5048321924 @default.
W4309107130 hasAuthorship W4309107130A5049712951 @default.
W4309107130 hasAuthorship W4309107130A5057320481 @default.
W4309107130 hasAuthorship W4309107130A5075010024 @default.
W4309107130 hasAuthorship W4309107130A5077263580 @default.
W4309107130 hasAuthorship W4309107130A5086648272 @default.
W4309107130 hasAuthorship W4309107130A5090313762 @default.
W4309107130 hasBestOaLocation W43091071301 @default.
W4309107130 hasConcept C126322002 @default.
W4309107130 hasConcept C134018914 @default.
W4309107130 hasConcept C160160445 @default.
W4309107130 hasConcept C181199279 @default.
W4309107130 hasConcept C185592680 @default.
W4309107130 hasConcept C20904676 @default.
W4309107130 hasConcept C2776877979 @default.
W4309107130 hasConcept C2778606649 @default.
W4309107130 hasConcept C2779679107 @default.
W4309107130 hasConcept C2779856020 @default.
W4309107130 hasConcept C515207424 @default.
W4309107130 hasConcept C55493867 @default.
W4309107130 hasConcept C71924100 @default.
W4309107130 hasConcept C86803240 @default.
W4309107130 hasConcept C98274493 @default.
W4309107130 hasConceptScore W4309107130C126322002 @default.
W4309107130 hasConceptScore W4309107130C134018914 @default.
W4309107130 hasConceptScore W4309107130C160160445 @default.
W4309107130 hasConceptScore W4309107130C181199279 @default.
W4309107130 hasConceptScore W4309107130C185592680 @default.
W4309107130 hasConceptScore W4309107130C20904676 @default.
W4309107130 hasConceptScore W4309107130C2776877979 @default.
W4309107130 hasConceptScore W4309107130C2778606649 @default.
W4309107130 hasConceptScore W4309107130C2779679107 @default.
W4309107130 hasConceptScore W4309107130C2779856020 @default.
W4309107130 hasConceptScore W4309107130C515207424 @default.
W4309107130 hasConceptScore W4309107130C55493867 @default.
W4309107130 hasConceptScore W4309107130C71924100 @default.
W4309107130 hasConceptScore W4309107130C86803240 @default.
W4309107130 hasConceptScore W4309107130C98274493 @default.
W4309107130 hasIssue "7" @default.
W4309107130 hasLocation W43091071301 @default.
W4309107130 hasLocation W43091071302 @default.
W4309107130 hasLocation W43091071303 @default.
W4309107130 hasLocation W43091071304 @default.
W4309107130 hasLocation W43091071305 @default.
W4309107130 hasLocation W43091071306 @default.
W4309107130 hasLocation W43091071307 @default.
W4309107130 hasOpenAccess W4309107130 @default.
W4309107130 hasPrimaryLocation W43091071301 @default.
W4309107130 hasRelatedWork W1535017972 @default.
W4309107130 hasRelatedWork W1970022001 @default.
W4309107130 hasRelatedWork W1990758898 @default.
W4309107130 hasRelatedWork W2072052922 @default.
W4309107130 hasRelatedWork W2165426876 @default.
W4309107130 hasRelatedWork W2605810819 @default.
W4309107130 hasRelatedWork W2748952813 @default.
W4309107130 hasRelatedWork W3004644447 @default.
W4309107130 hasRelatedWork W4309107130 @default.
W4309107130 hasRelatedWork W4362713629 @default.
W4309107130 hasVolume "41" @default.
W4309107130 isParatext "false" @default.